recent post

Counterfeit drugs remain a challenge for pharma companies-Suresh Subramanian, National Lifesciences Leader, EY Parthenon India

December 5, 2024
recent post

Automation in Action: How Tech is Revolutionising Clinical Diagnostics in India

recent post

Bajaj Finserv AMC launches Bajaj Finserv Healthcare Fund

recent post

ENTOD Pharmaceuticals ropes in Dr Anish Desai as Scientific & Research AdviserĀ 

recent post

LPU's International Conference of Pharmacy 2024 discuss ways to transform pharma landscape

Lupin completes acquisition of two brands from Sanofi in Europe and Canada

Lupin completes acquisition of two brands from Sanofi in Europe and Canada

The transaction aligns with Lupin's strategy to grow its global presence in specialty areas Lupin announced that its European hub entity, Lupin Atlantis Holdings, has completed the acquisition of two well-known brands, Aarane in Germany and Nalcrom in Canada and the Netherlands, along with the associated trademark rights, from Sanofi. The transaction aligns with Lupin's strategy to grow its global presence in speciality areas, where the company has a leading position, with high-quality products that are innovative or unique in the market. This acquisition will enhance Lupin's Respiratory business in Germany, by aiding in the expansion of the newly established franchise, following the introduction of Luforbec.